PCT (PCTL) 10-Q 14 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Nov. 14, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	000-31549
Entity Registrant Name	PCT LTD
Entity Central Index Key	0001119897
Entity Tax Identification Number	90-0578516
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	4235 Commerce Street
Entity Address, City or Town	Little River
Entity Address, State or Province	SC
Entity Address, Postal Zip Code	29566
City Area Code	(843)
Local Phone Number	390-7900
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		805,596,961

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash and cash equivalents	$ 31,458	$ 116,497
Accounts receivable, net	24,714	96,022
Inventory	38,614	36,954
Prepaid expenses		53,090
Other current assets	7,200	8,200
Total current assets	101,986	310,763
PROPERTY AND EQUIPMENT
Property and equipment, net	1,032,143	762,054
OTHER ASSETS
Intangible assets, net	2,872,138	3,098,021
Operating lease right-of-use asset	52,645	83,420
Total other assets	2,924,783	3,181,441
TOTAL ASSETS	4,058,912	4,254,258
CURRENT LIABILITIES
Accounts payable	561,664	72,873
Accrued expenses - related parties	230,492	226,844
Accrued expenses	845,913	691,364
Advances payable	500,000
Operating lease liability	48,213	42,012
Current portion of notes payable – related parties, net	177,650	85,850
Current portion of notes payable, net	404,049	133,144
Current portion of convertible notes payable, net	430,934	480,808
Derivative liability	1,026,338	3,044,034
Total current liabilities	4,225,253	4,776,929
LONG-TERM LIABILITIES
Convertible notes payable, net of current portion and discounts	1,465,300	1,465,300
Operating lease liability, net of current portion	4,432	41,408
TOTAL LIABILITIES	5,694,985	6,283,637
MEZZANINE EQUITY
Preferred series A stock, $0.001 par value; 1,000,000 authorized; 500,000 issued and outstanding at September 30, 2022 and December 31, 2021, respectively	60,398	60,398
Preferred series B stock, $0.001 par value; 1,000,000 authorized; 1,000,000 issued and outstanding at September 30, 2022 and December 31, 2021, respectively	158,247	158,247
Preferred series C stock, $0.001 par value; 1,500,000 authorized; 1,500,000 issued and outstanding at September 30, 2022 and December 31, 2021, respectively	2,250,000	2,250,000
TOTAL MEZZANINE EQUITY	2,468,645	2,468,645
STOCKHOLDERS' DEFICIT
Common stock, $0.001 par value; 1,000,000,000 authorized; 805,596,961 and 790,924,690 issued and outstanding at September 30, 2022 and December 31, 2021, respectively	805,596	790,924
Additional paid-in-capital	24,468,135	24,310,045
Accumulated deficit	(29,378,449)	(29,598,993)
TOTAL STOCKHOLDERS' DEFICIT	(4,104,718)	(4,498,024)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT	$ 4,058,912	$ 4,254,258

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	1,000,000,000	1,000,000,000
Common Stock, Shares, Issued	805,596,961	790,924,690
Common Stock, Shares, Outstanding	805,596,961	790,924,690
Series A Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	500,000	500,000
Preferred Stock, Shares Outstanding	500,000	500,000
Series B Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	1,000,000	1,000,000
Preferred Stock, Shares Outstanding	1,000,000	1,000,000
Series C Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	1,500,000	1,500,000
Preferred Stock, Shares Issued	1,500,000	1,500,000
Preferred Stock, Shares Outstanding	1,500,000	1,500,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
REVENUES
Product	$ 38,893	$ 33,279	$ 111,163	$ 204,138
Licensing	9,000	75,347	18,097	225,122
Equipment leases	241,604	258,104	744,812	802,132
Total Revenues	289,497	366,730	874,072	1,231,392
OPERATING EXPENSES
General and administrative	551,921	1,031,072	2,008,782	2,583,139
Research and development	119	14,783	5,444	29,738
Cost of product, licensing and equipment leases	6,321	85,591	81,112	225,960
Depreciation and amortization	125,414	98,364	357,799	295,092
Total operating expenses	683,775	1,229,810	2,453,137	3,133,929
Loss from operations	(394,278)	(863,080)	(1,579,065)	(1,902,537)
OTHER INCOME (EXPENSE)
Gain on change in fair value of derivative liability	51,008	457,116	2,061,774	1,749,277
Gain on settlement of debt	(1,011)	361,357	68,259	3,689,055
Interest expense	(154,182)	(101,580)	(330,424)	(378,223)
Misc. income				50,000
Total other income (expense)	(104,185)	716,893	1,799,609	5,110,109
Income (loss) before income taxes	(498,463)	(146,187)	220,544	3,207,572
Income taxes
NET (INCOME (LOSS)	$ (498,463)	$ (146,187)	$ 220,544	$ 3,207,572
Basic income (loss) per share	$ 0	$ 0	$ 0	$ 0
Diluted income (loss) per share	$ 0	$ 0	$ 0	$ 0
Basic weighted average shares outstanding	806,882,966	773,082,751	797,708,252	760,229,694
Diluted weighted average shares outstanding	806,882,966	773,082,751	899,948,629	1,024,432,537

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance - December 31, 2021 at Dec. 31, 2020	$ 722,488	$ 23,202,933	$ (30,587,612)	$ (6,662,191)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020	722,487,846
Common stock issued for services	$ 2,500	74,276		76,776
Stock Issued During Period, Shares, Issued for Services	2,500,000
Common stock issued in settlement of debt	$ 4,466	648,844		653,310
Stock Issued During Period, Shares, Other	4,466,508
Common stock issued in conversion of convertible notes payable	$ 25,000			25,000
Stock Issued During Period, Shares, Conversion of Convertible Securities	25,000,000
Conversion of preferred series C stock	$ 4,000	36,000		40,000
[custom:CommonStockIssuedInConversionOfPreferredSeriesCStockShares]	4,000,000
Net loss			(718,028)	(718,028)
Balance – September 30, 2022 at Mar. 31, 2021	$ 758,454	23,962,053	(31,305,640)	(6,585,133)
Shares, Outstanding, Ending Balance at Mar. 31, 2021	758,454,354
Balance - December 31, 2021 at Dec. 31, 2020	$ 722,488	23,202,933	(30,587,612)	(6,662,191)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020	722,487,846
[custom:CommonStockIssuedInConversionOfPreferredSeriesCStockShares]	4,000,000
Net loss				3,207,572
Common stock issued in cashless exercise of warrants				34,594
Balance – September 30, 2022 at Sep. 30, 2021	$ 780,126	24,349,886	(27,380,040)	(2,250,028)
Shares, Outstanding, Ending Balance at Sep. 30, 2021	780,126,229
Balance - December 31, 2021 at Dec. 31, 2020	$ 722,488	23,202,933	(30,587,612)	(6,662,191)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020	722,487,846
Balance – September 30, 2022 at Dec. 31, 2021	$ 790,924	24,310,045	(29,598,993)	(4,498,024)
Shares, Outstanding, Ending Balance at Dec. 31, 2021	790,924,690
Balance - December 31, 2021 at Mar. 31, 2021	$ 758,454	23,962,053	(31,305,640)	(6,585,133)
Shares, Outstanding, Beginning Balance at Mar. 31, 2021	758,454,354
Common stock issued for services	$ 1,000	32,174		33,174
Stock Issued During Period, Shares, Issued for Services	1,000,000
Net loss			4,071,787	4,071,787
Sale of Stock, Number of Shares Issued in Transaction	8,750,000
Common stock issued in cashless exercise of warrants	$ 1,922	32,672		34,594
[custom:StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants]	1,921,875
Balance – September 30, 2022 at Jun. 30, 2021	$ 770,126	24,193,149	(27,233,853)	(2,270,578)
Shares, Outstanding, Ending Balance at Jun. 30, 2021	770,126,229
Common stock issued for services	$ 2,000	40,737		42,737
Stock Issued During Period, Shares, Issued for Services	2,000,000
Common stock issued in conversion of convertible notes payable	$ 8,000	116,000		124,000
Stock Issued During Period, Shares, Conversion of Convertible Securities	8,000,000
Net loss			(146,187)	(146,187)
Balance – September 30, 2022 at Sep. 30, 2021	$ 780,126	24,349,886	(27,380,040)	(2,250,028)
Shares, Outstanding, Ending Balance at Sep. 30, 2021	780,126,229
Balance - December 31, 2021 at Dec. 31, 2021	$ 790,924	24,310,045	(29,598,993)	(4,498,024)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	790,924,690
Net loss			468,049	468,049
Stock-based compensation		7,952		7,952
Balance – September 30, 2022 at Mar. 31, 2022	$ 790,924	24,317,997	(29,130,944)	(4,022,023)
Shares, Outstanding, Ending Balance at Mar. 31, 2022	790,924,690
Balance - December 31, 2021 at Dec. 31, 2021	$ 790,924	24,310,045	(29,598,993)	(4,498,024)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	790,924,690
Net loss				220,544
Common stock issued in cashless exercise of warrants
Balance – September 30, 2022 at Sep. 30, 2022	$ 805,596	24,468,135	(29,378,449)	(4,104,718)
Shares, Outstanding, Ending Balance at Sep. 30, 2022	805,596,961
Balance - December 31, 2021 at Mar. 31, 2022	$ 790,924	24,317,997	(29,130,944)	(4,022,023)
Shares, Outstanding, Beginning Balance at Mar. 31, 2022	790,924,690
Common stock issued in conversion of convertible notes payable	$ 16,644	108,876		125,520
Stock Issued During Period, Shares, Conversion of Convertible Securities	16,644,146
Net loss			250,958	250,958
Stock-based compensation		21,422		21,422
Balance – September 30, 2022 at Jun. 30, 2022	$ 807,568	24,448,295	(28,879,986)	(3,624,123)
Shares, Outstanding, Ending Balance at Jun. 30, 2022	807,568,836
Net loss			(498,463)	(498,463)
Stock-based compensation		17,868		17,868
Return and cancellation of common shares	$ (1,972)	1,972
[custom:StockReturnCancellationDuringPeriodShares]	(1,971,875)
Balance – September 30, 2022 at Sep. 30, 2022	$ 805,596	$ 24,468,135	$ (29,378,449)	$ (4,104,718)
Shares, Outstanding, Ending Balance at Sep. 30, 2022	805,596,961

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net income	$ 220,544	$ 3,207,572
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	357,799	295,092
Amortization of debt discount	133,596	240,413
Common stock issued for services		267,830
(Gain) loss on change in fair value of derivative liability	(2,061,774)	(1,749,277)
Amortization of right of use asset	30,775	39,182
(Gain) loss on settlement of debt	(68,259)	(3,689,055)
Default penalties on convertible notes		15,172
Stock-based compensation	47,242
Changes in operating assets and liabilities:
Accounts receivable	71,308	3,679
Inventory	(1,660)	(6,130)
Prepaid expenses	53,090	(8,543)
Deposits		9,726
Other assets	1,000	(16,740)
Operating lease liability	(30,775)	(39,182)
Accounts payable	488,791	(212,125)
Accrued expenses - related party	3,648	14,887
Accrued expenses	166,989	165,479
Net cash used in operating activities	(587,686)	(1,279,320)
Cash Flows from Investing Activities
Purchase of equipment	(402,005)	(28,138)
Net cash used for by investing activities	(402,005)	(28,138)
Cash Flows from Financing Activities
Proceeds from advances payable	500,000	1,450,000
Proceeds from notes payable	463,965	410,377
Proceeds from notes payable - related parties	96,800
Proceeds from convertible notes payable	225,000	920,000
Proceeds from sale of common stock		175,000
Repayment of convertible notes payable	(120,465)	(673,989)
Repayment of notes payable	(255,648)	(796,036)
Repayment of notes payable - related parties	(5,000)	(53,763)
Net cash provided by financing activities	904,652	1,431,589
Net change in cash	(85,039)	124,131
Cash and cash equivalents at beginning of period	116,497	115,196
Cash and cash equivalents at end of period	31,458	239,327
Supplemental Cash Flow Information
Cash paid for interest	122,054	72,763
Cash paid for income taxes
Non-cash investing and financing activities:
Original debt discount against convertible notes	9,000	12,000
Original debt discount against notes payable	82,435	174,435
Initial derivative on convertible note	113,348
Cancellation of common stock	1,972
Note payable settled for non-cash consideration	122,900
Common stock issued for services		81,740
Common stock issued in conversion of convertible notes payable	125,250	149,000
Common stock issued in settlement of notes payable to related parties		653,310
Common stock issued in cashless exercise of warrants		34,594
Common stock issued in conversion of preferred series C stock		$ 40,000

NOTE 1. BASIS OF PRESENTATION A

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The unaudited interim condensed consolidated financial statements of PCT LTD (the “Company”) have been prepared in accordance with United States generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and reflect all adjustments which, in the opinion of management, are necessary for a fair presentation of our balance sheet, statements of operations, stockholders’ equity (deficit), and cash flows for the periods presented. All such adjustments are of a normal recurring nature. The results of operations for the interim period are not necessarily indicative of the results to be expected for a full year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2021 audited financial statements as reported in its Form 10-K, filed on March 31, 2022. COVID-19 In December 2019 COVID-19 emerged in Wuhan, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to almost all other countries, including the United States, and infections have been reported globally. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. Additional, more restrictive proclamations and/or directives may be issued in the future. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Any resulting financial impact cannot be reasonably estimated at this time but may have a material impact on our business, financial condition and results of operations. The significance of the impact of the COVID-19 outbreak on the Company’s businesses and the duration for which it may have an impact cannot be determined at this time. At a minimum, the COVID-19 pandemic caused the Company to restrict travel of its personnel and to initiate distributor installations of certain of the Company’s equipment, as possible. The Company adapted to the immediate need for its US EPA registered disinfectant at the end of March and beginning of April, 2020, but installing greater storage reserves and by assembling more of it higher-volume equipment to produce the hospital grade disinfectant known as Hydrolyte®. There were hard costs associates with these adaptations to the Little River, SC facility, but the Company continues to benefit from its fluid production capacities over the longer term. As the Federal, state and other restrictions associated with the pandemic have lessened, the Company is able to act more effectively in obtaining new contracts for its healthcare equipment, the Annihilyzer®. Nature of Operations PCT LTD (the “Company” or “PCT LTD”), a Delaware corporation, was formed on February 27, 1986. The Company changed its domicile to Nevada on August 26, 1998. The Company acquires, develops and provides sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The Company specializes in providing cleaning, sanitizing, and disinfectant fluid solutions and fluid-generating equipment that creates environmentally safe solutions for global sustainability. On August 31, 2016, the Company entered into a Securities Exchange Agreement with Paradigm Convergence Technologies Corporation (“Paradigm,” or “PCT Corp.”) to effect the acquisition of Paradigm as a wholly-owned subsidiary. Paradigm is located in Little River, SC, was formed June 6, 2012, and is a technology licensing company specializing in environmentally safe solutions for global sustainability. Paradigm holds a patent, intellectual property and/or distribution rights to innovative products and technologies. Paradigm provides innovative products and technologies for eliminating biocidal contamination from water supplies, industrial fluids, hard surfaces, food-processing equipment and medical devices. Paradigm’s overall strategy is to market new products and technologies through the use of equipment leasing, joint ventures, licensing, distributor agreements and partnerships. Effective on February 29, 2018, the Company changed its name from Bingham Canyon Corporation to PCT LTD. to more accurately identify the Company’s direction and to develop the complementary relationship and association with its wholly-owned operating company, Paradigm. On July 11, 2021, the Company incorporated two wholly-owned subsidiaries, Disruptive Oil and Gas Technologies Corp. (“Disruptive”) and Technologies Development Corp., both in the State of Nevada. On October 20, 2021, the Company sold a 53.75% interest in Disruptive in consideration for the assignment of certain patents to Disruptive and realized no gain or loss on the sale. On April 12, 2022, the Company incorporated two wholly-owned subsidiaries, 21 st st Significant Accounting Policies There have been no changes to the significant accounting policies of the Company from the information provided in Note 1 of the Notes to the Consolidated Financial Statements in the Company's most recent Form 10-K. Basic and Diluted Loss Per Share Basic income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as options, warrants, convertible notes payable, preferred series A stock and preferred series C stock. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, for the three months and nine months ended September 30, 2022, there were outstanding common share equivalents which amounted to 331,667,447 and 231,733,160 shares of common stock, respectively, that were not included in the calculation as their effect is anti-dilutive. For fiscal periods with net losses, these common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive. Three months ended September 30, 2022 Three months ended September 30, 2021 Nine months Nine months Numerator: Net income (loss) (498,463 ) (146,187 ) 220,544 3,207,572 (Gain) loss on change in fair value of derivative liability — — (1,835,014 ) (1,641,616 ) Gain on settlement of debt — — (69,270 ) (3,792,104 ) Interest expense — — — 30,617 Adjusted net income (loss) (498,463 ) (146,187 ) (1,683,740 ) (2,195,531 ) Denominator: Weighted average shares outstanding used in computing net income (loss) per share Basic 806,882,966 773,082,751 797,708,252 760,229,694 Effect of dilutive warrants — — 101,723,677 203,745,854 Effect of convertible note weighted shares — — 516,700 60,456,989 Diluted 806,882,966 773,082,751 899,948,629 1,024,432,537 Net income (loss) per share applicable to common shareholders: Basic $ (0.00 ) $ (0.00 ) $ 0.00 $ 0.00 Diluted $ (0.00 ) $ (0.00 ) $ (0.00 ) $ (0.00 ) Recent Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40)” (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU’s amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its financial statements. The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE 2. GOING CONCERN

NOTE 2. GOING CONCERN	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NOTE 2. GOING CONCERN	NOTE 2. GOING CONCERN The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has an accumulated deficit of $ 29,378,449 4,123,267 The Company expects that working capital requirements will continue to be funded through a combination of its existing funds and further issuances of securities. Working capital requirements are expected to increase in line with the growth of the business. The Company has no lines of credit or other bank financing arrangements. The Company has financed operations to date through the proceeds of private placement of equity and debt instruments. In connection with the Company’s business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) developmental expenses associated with business growth and (ii) marketing expenses. The Company intends to finance these expenses with further issuances of securities, and debt issuances. Thereafter, the Company expects it will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to current stockholders. Further, such securities might have rights, preferences or privileges senior to common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict business operations.

NOTE 3. PROPERTY AND EQUIPMENT

NOTE 3. PROPERTY AND EQUIPMENT	9 Months Ended
	Sep. 30, 2022
PROPERTY AND EQUIPMENT
NOTE 3. PROPERTY AND EQUIPMENT	NOTE 3. PROPERTY AND EQUIPMENT Property and equipment at September 30, 2022 and December 31, 2021 consisted of the following: September 30, 2022 December 31, 2021 Leasehold improvements $ 61,846 $ 61,580 Machinery and leased equipment 433,417 365,483 Machinery and equipment not yet in service 732,572 440,150 Office equipment and furniture 99,296 57,913 Website 2,760 2,760 Total property and equipment $ 1,329,891 $ 927,886 Less: Accumulated Depreciation (297,748 ) (165,832 ) Property and equipment, net $ 1,032,143 $ 762,054 Depreciation expense was $ 131,916 66,726 292,422

NOTE 4. INTANGIBLE ASSETS

NOTE 4. INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
NOTE 4. INTANGIBLE ASSETS	NOTE 4. INTANGIBLE ASSETS Intangible assets at September 30, 2022 and December 31, 2021 consisted of the following: September 30, 2022 December 31, 2021 Patents $ 4,505,489 $ 4,505,489 Technology rights 200,000 200,000 Intangibles, at cost 4,705,489 4,705,489 Less: Accumulated amortization (1,833,351 ) (1,607,468 ) Net Carrying Amount $ 2,872,138 $ 3,098,021 Amortization expense was $ 225,883 228,366 Estimated Future Amortization Expense: $ For year ending December 31, 2022 75,501 For year ending December 31, 2023 302,003 For year ending December 31, 2024 302,003 For year ending December 31, 2025 302,003 For year ending December 31, 2026 302,003 Thereafter 1,588,625 Total 2,872,138

NOTE 5. LEASES

NOTE 5. LEASES	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
NOTE 5. LEASES	NOTE 5. LEASES On August 26, 2020, the Company signed a new one-year lease for the Company headquarters and operations located in Little River, South Carolina. The lease was effective retroactively from July 1, 2020, ending on June 30, 2021, for $ 7,500 7,650 7,803 On October 19, 2020, the Company entered into a building lease with a three-year term and an effective date of November 1, 2020. The lease requires the Company to make payments of $ 4,500 13,500 At September 30, 2022, the weighted average remaining operating lease term was 1.08 years and the weighted average discount rate associated with operating leases was 18.5%. The components of lease expenses for the nine-month period ended September 30, 2022 and 2021 were as follows: 2022 2021 $ Total operating lease cost 40,500 59,750 The following table provides supplemental cashflow and other information related to leases for the nine-month period ended September 30, 2022 and 2021: 2022 2021 $ Lease payments 109,809 127,700 Supplemental balance sheet information related to leases as of September 30, 2022 and 2021 are as below: 2022 2021 $ Cost 123,614 176,213 Accumulated amortization (70,969 ) (44,411 ) Impairment — (39,030 ) Net carrying value 52,645 92,772 Future minimum lease payments related to lease obligations are as follows as of September 30, 2022: $ 2022 13,500 2023 45,000 Total minimum lease payments 58,500 Less: amount of lease payments representing effects of discounting (5,855 ) Present value of future minimum lease payments 52,645 Less: current obligations under leases (48,213 ) Lease liabilities, net of current portion 4,432

NOTE 6. Notes Payable

NOTE 6. Notes Payable	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
NOTE 6. Notes Payable	NOTE 6. Notes Payable The following tables summarize notes payable as of September 30, 2022 and December 31, 2021: Type Original Amount Origination Date Maturity Date Effective Annual Interest Rate Balance at September 30, 2022 Balance at December 31, 2021 Note Payable ** $ 25,000 05/08/2017 06/30/2018 0 % $ 20,000 $ 22,500 Note Payable ** $ 118,644 05/05/2020 05/05/2021 8 % $ 110,644 $ 110,644 Note Payable (a) $ 199,000 02/04/2022 02/03/2023 0 % $ — $ — Note Payable (b) $ 131,100 03/04/2022 12/16/2022 83 % $ 40,457 $ — Note Payable (c) $ 81,600 04/13/2022 01/05/2023 87 % $ 32,063 — Note Payable (d) $ 200,000 7/13/2022 7/11/2023 70 % $ 177,439 — Note Payable (e) $ 57,600 8/15/2022 2/13/2023 171 % $ 44,308 — Sub-total $ 424,911 $ 133,144 Debt discount $ (20,862 ) $ — Balance, net $ 404,049 $ 133,144 Less current portion $ (404,049 ) $ (133,144 ) Total long-term $ — $ — ** Currently in default a) On February 4, 2022, the Company entered into a loan agreement with a non-related party for $ 199,000 2,985 196,015 5,013 2,985 117,312 122,900 1,011 0 b) On March 4, 2022, the Company sold future receivables with a non-related party for $ 131,100 36,100 95,000 3,121 32,518 90,643 40,457 3,582 c) On April 13, 2022, the Company sold future receivables with a non-related party for $ 81,600 21,600 60,000 2,147 18,133 49,537 32,063 3,467 d) On July 13, 2022, the Company entered into a loan agreement with a non-related party for $ 200,000 2,500 122,900 74,600 5,308 878 42,462 177,439 1,622 e) On August 15, 2022, the Company sold future receivables with a non-related party for $ 57,600 17,600 40,000 2,215 8,113 13,292 44,308 12,191 The following table summarizes notes payable, related parties as of September 30, 2022 and December 31, 2021: Type Original Amount Origination Date Maturity Date Annual Interest Rate Balance at September 30, 2022 Balance at December 31, 2021 Note Payable, RP ** $ 17,000 06/20/2018 01/02/2020 5 % $ 10,000 $ 10,000 Note Payable, RP ** $ 50,000 07/27/2018 11/30/2018 8 % $ 10,850 $ 10,850 Note Payable, RP ** $ 15,000 08/16/2019 02/16/2020 8 % $ 15,000 $ 15,000 Note Payable, RP (f) $ 84,034 02/16/2021 Demand 5 % $ 45,000 $ 50,000 Note Payable, RP (g) $ 9,000 06/15/2022 12/31/2022 0 % $ 9,000 $ — Note Payable, RP (g) $ 5,000 06/24/2022 12/31/2022 0 % $ 5,000 $ — Note Payable, RP (g) $ 41,300 06/29/2022 12/31/2022 0 % $ 41,300 $ — Note Payable, RP (h) $ 15,500 07/07/2022 12/31/2022 0 % 15,500 — Note Payable, RP (i) $ 3,500 08/19/2022 12/31/2022 0 % 3,500 — Note Payable, RP (j) $ 22,500 09/02/2022 12/31/2022 0 % 22,500 — Subtotal $ 177,650 $ 85,850 Debt discount $ — $ — Balance, net $ 177,650 $ 85,850 Less current portion $ (177,650 ) $ (85,850 ) Total long-term $ — $ — ** Currently in default f) On March 7, 2022, the Company repaid the principal amount of $ 5,000 45,000 g) During June 2022, the Company entered into three promissory notes with the CFO of the Company for an aggregate principal amount of $ 55,300 0 h) On July 7, 2022, the Company entered into a promissory note with the CFO of the Company for a principal amount of $ 15,500 0 i) On August 19, 2022, the Company entered into a promissory note with the CFO of the Company for a principal amount of $ 3,500 0 j) On September 2, 2022, the Company entered into a promissory note with the CFO of the Company for a principal amount of $ 22,500 0 The following table summarizes convertible notes payable as of September 30, 2022 and December 31, 2021: Type Original Amount Origination Date Maturity Date Annual Interest Rate Balance at September 30, 2022 Balance at December 31, 2021 Convertible Note Payable (k) * ** $ 150,000 04/10/2020 04/09/2021 12 % $ — $ 25,000 Convertible Note Payable (l) $ 300,000 08/27/2020 07/31/2021 12 % $ 265,000 $ 270,000 Convertible Note Payable (m) $ 226,162 11/04/2021 11/04/2022 19 % $ — $ 203,546 Convertible Note Payable $ 1,465,300 11/30/2021 11/30/2023 5 % $ 1,465,300 $ 1,465,300 Convertible Note Payable (n) ** $ 128,000 03/29/2022 03/29/2023 12 % $ 128,000 $ — Convertible Note Payable (o) $ 53,000 06/01/2022 06/01/2023 12 % $ 53,000 $ — Convertible Note Payable (p) $ 53,000 06/14/2022 06/14/2023 12 % $ 53,000 $ — Subtotal $ 1,964,300 $ 1,963,846 Debt discount $ (68,066 ) $ (17,738 ) Balance, net $ 1,896,234 $ 1,946,108 Less current portion $ (430,934 ) $ (480,808 ) Total long-term $ 1,465,300 $ 1,465,300 * Embedded conversion feature accounted for as a derivative liability at period end ** Currently in default k) During the nine months ended September 30, 2022, the Company repaid $ 25,000 0 l) During the nine months ended September 30, 2022, the Company repaid $ 5,000 265,000 m) During the nine months ended September 30, 2022, $ 17,738 90,465 16,644,146 0 n) On March 29, 2022, the Company entered into a convertible promissory note with a non-related party for $ 128,000 500 2,500 12 113,348 52,436 o) On June 1, 2022, the Company entered into a convertible promissory note with a non-related party for $ 53,000 500 2,500 50,000 12 976 p) On June 14, 2022, the Company entered into a convertible promissory note with a non-related party for $ 53,000 500 2,500 50,000 12 870

NOTE 7. DERIVATIVE LIABILITIES

NOTE 7. DERIVATIVE LIABILITIES	9 Months Ended
	Sep. 30, 2022
Note 7. Derivative Liabilities
NOTE 7. DERIVATIVE LIABILITIES	NOTE 7. DERIVATIVE LIABILITIES The embedded conversion option of (1) the convertible debentures described in Note 6 and (2) warrants, containing conversion features that qualify for embedded derivative classification. The fair value of the liabilities will be re-measured at the end of every reporting period and the change in fair value will be reported in the statement of operations as a gain or loss on derivative financial instruments. Upon the issuance of the convertible notes payable described in Note 6, the Company concluded that it only has sufficient shares to satisfy the conversion of some but not all of the outstanding convertible notes, warrants and options. The Company elected to reclassify contracts from equity with the earliest inception date first. As a result, none of the Company’s previously outstanding convertible instruments qualified for derivative reclassification, however, any convertible securities issued after the election, including the warrants described in Note 10, qualified for derivative classification. The Company reassesses the classification of the instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. The table below sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities. September 30, December 31, Balance at the beginning of period $ 3,044,034 $ 7,102,801 Discount upon recognition of conversion feature 113,348 — Settlement of derivative instruments (69,270 ) (4,035,906 ) Change in fair value of embedded conversion option (2,061,774 ) (22,861 ) Balance at the end of the period $ 1,026,338 $ 3,044,034 The Company uses Level 3 inputs for its valuation methodology for the embedded conversion option and warrant liabilities as their fair values were determined by using the Binomial Model based on various assumptions. Significant changes in any of these inputs in isolation would result in a significant change in the fair value measurement. As required, these are classified based on the lowest level of input that is significant to the fair value measurement. The following table shows the assumptions used in the calculations: Expected Volatility Risk-free Interest Rate Expected Dividend Yield Expected Life (in years) At September 30, 2022 108 199 3.92 4.25 0 % 0.49 2.91

NOTE 8. STOCKHOLDERS' DEFICIT

NOTE 8. STOCKHOLDERS' DEFICIT	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
NOTE 8. STOCKHOLDERS' DEFICIT	NOTE 8. STOCKHOLDERS' DEFICIT Preferred Stock Effective March 23, 2018, the Company amended the articles of incorporation and authorized 10,000,000 0.001 Series A Preferred Shares On December 1, 2018, the Company’s Board of Directors authorized an offering for 1,000,000 0.10 60,000 600,000 On April 12, 2019, the Company filed a Certificate of Designation with the Nevada Secretary of State designating 1,000,000 Issue Price The stated price for the Series A Preferred shall be $0.10 per share. Redemption This Company may at any time following the first anniversary date of issuance (the “Redemption Date”), at the option of the Board of Directors, redeem in whole or in part the Shares by paying in cash in exchange for the Shares to be redeemed a price equal to the Original Series A Issue Price ($0.10) (the “Redemption Price”). Any redemption affected pursuant to this provision shall be made on a pro rata basis among the holders of the Shares in proportion to the number of the shares then held by them. Dividends None. Preference of Liquidation In the event of any liquidation, dissolution or winding up of the Company, the holders of Shares shall be entitled to receive, prior and in preference to any distribution of any of the assets of this Company, to the holders of Common Stock by reason of their ownership thereof, an amount per share equal to the sum of (i) $0.10 for each outstanding Share (the “Original Series A Issue Price”) and (ii) an amount equal to 6% of the Original Series A Issue Price for each 12 months that has passed since the date of issuance of any Shares (such amount being referred to herein as the “Premium”). For purposes of this provision, a liquidation, dissolution or winding up of this Company shall be deemed to be occasioned by, or to include, (A) the acquisition of the Company by another entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation but, excluding any merger effected exclusively for the purpose of changing the domicile of the Company); or (B) a sale of all or substantially all of the assets of the Company; unless the Company’s stockholders of record as constituted immediately prior to such acquisition or sale will, immediately after such acquisition or sale (by virtue of securities issued as consideration for the Company’s acquisition or sale or otherwise), hold at least 50% of the voting power of the surviving or acquiring entity. If upon the occurrence of such liquidation, dissolution or winding up event, the assets and funds thus distributed among the holders of the Shares shall be insufficient to permit the payment to such holders of the full aforesaid preferential amounts, then, subject to the rights of series of preferred stock that may from time to time come into existence, the entire assets and funds of the Company legally available for distribution shall be distributed ratably among the holders of the Shares in proportion to the preferential amount each such holder is otherwise entitled to receive. In any of such liquidation, dissolution or winding up event, if the consideration received by the Company is other than cash, its value will be deemed its fair market value. Any securities shall be valued as follows: A. Securities not subject to investment letter or other similar restrictions on free marketability (covered by (B) below): 1) If traded on a securities exchange (NASDAQ, AMEX, NYSE, etc.), the value shall be deemed to be the average of the closing prices of the securities on such exchange over the thirty-day period ending three (3) days prior to the closing; 2) If traded on a quotation system, such as the OTC:QX, OTC:QB or OTC Pink Sheets, the value shall be deemed to be the average of the closing bid or sale prices (whichever is applicable) over the thirty-day period ending three (3) days prior to the closing; and 3) If there is no active public market, the value shall be the fair market value thereof, as mutually determined by the Company and the holders of at least a majority of the voting power of all then outstanding shares of Preferred Stock. B. The method of valuation of securities subject to investment letter or other restrictions on free marketability (other than restrictions arising solely by virtue of a stockholder's status as an affiliate or former affiliate) shall be to make an appropriate discount from the market value determined as above in (A) (1), (2) or (3) to reflect the approximate fair market value thereof, as mutually determined by the Company and the holders of at least a majority of the voting power of all then outstanding shares of such Preferred Stock: Voting The holder of each Share shall not have any voting rights, except in the case of voting on a change in the preferences of Shares. Conversion Each Share shall be convertible into shares of the Company’s Common Stock at a price per share of $0.10 (1 Share converts into 1 share of Common Stock), at the option of the holder thereof, at any time following the date of issuance of such Share and on or prior to the fifth day prior to the Redemption Date, if any, as may have been fixed in any Redemption Notice with respect to the Shares, at the office of this Company or any transfer agent for such stock. Each Share shall automatically be converted into shares of Common Stock on the first day of the thirty-sixth (36th) month following the original issue date of the shares at the Conversion Price per share. To date, the Shares have not yet been converted into Common Stock. The Company was unable to issue the subscribers the preferred shares until the Company filed a Certificate of Designation and the Preferred Series “A” stock had been duly validly authorized. As the Company had not filed the Certificate of Designation and as the Company could not issue the preferred shares to settle the proceeds received, it was determined the subscriptions were settleable in cash. As a result, the Company classified the subscriptions received as a liability in accordance with ASC 480 Distinguishing Liabilities from Equity. The filing of the Certificate of Designation and issuance of the preferred shares in 2019 resulted in the reclassification of the Series A Preferred Shares from a liability to temporary equity or “mezzanine” because the preferred shares include the liquidation preferences described above. The fair value of the preferred series A stock on April 12, 2019 was $60,398 and was valued by using the Binomial Model based on various assumptions and was reclassified from a liability to mezzanine equity. As of September 30, 2022, and December 31, 2021, there were 500,000 Series B Preferred Shares Effective August 13, 2019, the Company filed a Certificate of Designation with the Nevada Secretary of State thereby designating 1,000,000 Voting Rights Holders of the Series B Preferred Stock shall be entitled to cast five hundred (500) votes for each share held of the Series B Preferred Stock on all matters presented to the stockholders of the Corporation for stockholder vote which shall vote along with holders of the Corporation’s Common Stock on such matters. Redemption Rights The Series B Preferred Stock shall be redeemed by the Corporation upon the successful receipt by the Corporation of at least $1,000,000 in equity capital following the issuance of the Series B Preferred Stock. The Company has received in excess of $1,000,000 of equity capital during the year ended December 31, 2021, and the redemption right has been triggered. However, to date the Company has not exercised the redemption rights to redeem the Series B Preferred Stock and currently has no plans to do so. Conversion Rights The Series B Preferred Stock is not convertible into shares of Common Stock of the Corporation. Protective Provisions So long as any shares of Series B Preferred Stock are outstanding, this Corporation shall not without first obtaining the approval (by vote or written consent, as provided by law) of the Holders of the Series B Preferred Stock which is entitled, other than solely by law, to vote with respect to the matter, and which Preferred Stock represents at least a majority of the voting power of the then outstanding shares of such Series B Preferred Stock: a) sell, convey, or otherwise dispose of or encumber all or substantially all of its property or business or merge into or consolidate with any other corporation (other than a wholly owned subsidiary corporation) or effect any transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Corporation is disposed of; b) alter or change the rights, preferences or privileges of the shares of Series B Preferred Stock so as to affect adversely the shares; c) increase or decrease (other than by redemption or conversion) the total number of authorized shares of preferred stock; d) authorize or issue, or obligate itself to issue, any other equity security, including any other security convertible into or exercisable for any equity security (i) having a preference over, or being on a parity with, the Series B Preferred Stock with respect to dividends or upon liquidation, or (ii) having rights similar to any of the rights of the Series B Preferred Stock; or e) amend the Corporation’s Articles of Incorporation or bylaws. Dividends None. Preference of Liquidation None. Upon designation, the Company issued 500,000 1,000,000 158,247 As of September 30, 2022, and December 31, 2021, there were 1,000,000 Series C Preferred Shares Pursuant to the September 18, 2019, the Company filed a Certificate of Designation with the Nevada Secretary of State designating 5,500,000 The number of shares constituting the Series C Convertible Preferred Stock shall be 5,500,000 Conversion Rights Each Share shall be convertible into shares of the Company’s Common Stock at a price per share of $0.01 (1 Share converts into 100 shares of Common Stock) (the “Conversion Price”), at the option of the holder thereof, at any time following the date of issuance of such Share and on or prior to the fifth (5th) day prior to the redemption Date, if any, as may have been fixed in any redemption notice with respect to the Shares, at the office of this Company or any transfer agent for such stock. Voting Rights The holder of each Share shall not have any voting rights, except in the case of voting on a change in the preferences of Shares. Protective Provisions So long as any Shares are outstanding, this Company shall not without first obtaining the approval (by vote or written consent, as provided by law) of the holders of Shares which is entitled, other than solely by law, to vote with respect to the matter, and which Shares represents at least a majority of the voting power of the then outstanding Shares: a) sell, convey, or otherwise dispose of or encumber all or substantially all of its property or business or merge into or consolidate with any other corporation (other than a wholly owned subsidiary corporation) or effect any transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Company is disposed of; b) alter or change the rights, preferences or privileges of the Shares so as to affect adversely the Shares; c) increase or decrease (other than by redemption or conversion) the total number of authorized shares of preferred stock; d) authorize or issue, or obligate itself to issue, any other equity security, including any other security convertible into or exercisable for any equity security (i) having a preference over, or being on a parity with, the Shares with respect to liquidation, or (ii) having rights similar to any of the rights of the Preferred Stock; or e) amend the Company’s Articles of Incorporation or bylaws. Other Rights There are no other rights, privileges or preferences attendant or relating to in any way the Shares, including by way of illustration but not limitation, those concerning dividend, ranking, other conversion, other redemption, participation or anti-dilution rights or preferences. As conversion of the Series C Preferred Shares is not within the control of the Company, and it is not certain that the Company could satisfy its obligation to deliver shares upon conversion, the Series C Preferred Shares were classified in temporary equity or “mezzanine”. On February 15, 2021, 40,000 4,000,000 Effective December 1, 2021, the Company filed an Amended and Restated Certificate of Designation with the Nevada Secretary of State designating 1,500,000 The amended number of shares constituting the Series C Convertible Preferred Stock shall be 1,500,000 Amended Conversion Rights Each Share shall be convertible into shares of the Company’s Common Stock at a price per share of $0.015 (1 Share converts into 150 shares of Common Stock) (the “Conversion Price”), at the option of the holder thereof, at any time following the date of issuance of such Share and on or prior to the fifth (5th) day prior to the redemption Date, if any, as may have been fixed in any redemption notice with respect to the Shares, at the office of this Company or any transfer agent for such stock. During the year ended December 31, 2021, the Company sold 1,500,000 2,250,000 As of September 30, 2022, and December 31, 2021, there were 1,500,000 Common Stock The authorized shares of common stock consists of 1,000,000,000 0.001 805,596,961 790,924,690 On May 26, 2022, $ 12,500 1,453,488 On June 1, 2022, $ 12,500 1,506,024 On June 2, 2022, $ 15,000 1,973,684 On June 6, 2022, $ 20,000 2,597,403 On June 8, 2022, $ 30,000 3,947,368 On June 13, 2022, $ 20,000 2,702,703 On June 21, 2022, $ 15,520 2,463,476 On August 31, 2022, 1,971,875

NOTE 9. STOCK OPTIONS

NOTE 9. STOCK OPTIONS	9 Months Ended
	Sep. 30, 2022
Note 9. Stock Options
NOTE 9. STOCK OPTIONS	NOTE 9. STOCK OPTIONS Below is a table summarizing the options issued and outstanding as of September 30, 2022: Number of options Weighted average exercise price Balance, December 31, 2021 8,500,000 0.034 Granted 7,000,000 0.067 Expired/Cancelled (6,500,000 ) 0.039 Settled — — Balance, September 30, 2022 9,000,000 0.056 Exercisable 3,500,000 0.021 As at September 30, 2022, the following share stock options were outstanding: Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 09/01/2021 2,000,000 2,000,000 0.015 3.92 08/31/2026 30,000 04/01/2021 1,500,000 1,500,000 0.03 4.92 08/31/2027 45,000 04/01/2021 1,500,000 — 0.05 5.92 08/31/2028 75,000 04/01/2021 2,000,000 — 0.075 6.92 08/31/2029 150,000 04/01/2021 2,000,000 — 0.10 7.92 08/31/2030 200,000 9,000,000 3,500,000 $ 500,000 At September 30, 2022, the weighted average exercise prices are $ 0.056 0.021 0 During the nine months ended September 30, 2022, the Company revised the terms of an employment agreement with the CFO to increase the amount of unvested stock options from 4,000,000 to 7,000,000 which shall vest incrementally over four years in the following manner: 1,500,000 stock options on September 1, 2022, 1,500,000 stock options on September 1, 2023, 2,000,000 stock options on September 1, 2024 and the final 2,000,000 stock options on September 1, 2025. Upon modification of the stock options, the Company calculated the incremental compensation cost of $42,899, which will be amortized to expense over the vesting period.

NOTE 10. WARRANTS

NOTE 10. WARRANTS	9 Months Ended
	Sep. 30, 2022
Note 10. Warrants
NOTE 10. WARRANTS	NOTE 10. WARRANTS The Company concluded that it only has sufficient shares to satisfy the conversion of some but not all of the outstanding convertible instruments. The initial fair value of the warrants issued during the period was calculated using the Binomial Model as described in Note 7. The following table summarizes the continuity of share purchase warrants: Number of Weighted average exercise price Balance, December 31, 2021 115,048,858 0.00597 Cancelled — — Granted — — Exercised — — Balance, September 30, 2022 115,048,858 0.00597 As at September 30, 2022, the following share purchase warrants were outstanding: Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 12/3/2018 500,000 500,000 * 0.10 1.18 12/3/2023 50,000 3/31/2019 104,548,858 * 104,548,858 * 0.00035 * 1.45 03/13/2024 36,592 8/26/2020 10,000,000 10,000,000 0.06 2.91 8/26/2025 600,000 115,048,858 115,048,858 $ 686,592 *The number of warrants outstanding and exercisable is variable based on adjustments to the exercise price of the warrant due to dilutive issuances. The intrinsic value of warrants outstanding at September 30, 2022 was $ 737,069

NOTE 11. RELATED PARTY TRANSACT

NOTE 11. RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
NOTE 11. RELATED PARTY TRANSACTIONS	NOTE 11. RELATED PARTY TRANSACTIONS The Company has agreements with related parties for consulting services, accrued rent, accrued interest, notes payable and stock options. See Notes to Financial Statements numbers 6, 8, and 9 for more details.

NOTE 12. COMMITMENTS AND CONTIN

NOTE 12. COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
NOTE 12. COMMITMENTS AND CONTINGENCIES	NOTE 12. COMMITMENTS AND CONTINGENCIES Consulting Agreements On March 1, 2021, the Company entered into a consulting agreement. Pursuant to the agreement, the consultant will provide consulting services to the Company in various marketing and management matters for a period of three months. In consideration for the services performed by the consultant, the Company agreed to compensate the consultant $ 5,000 2,500,000 0.0001 The Company also uses the professional services of securities attorneys, a US EPA specialist, professional accountants, and other public-company specialists. Employment Agreements - On April 1, 2022, the Company entered into an amended and restated four-year employment agreement with Arthur E. Abraham, replacing the former employment agreement dated September 1, 2021, to add the role of President. The terms of the revised agreement increases the amount of unvested stock options from 4,000,000 to 7,000,000 which shall vest incrementally over four years in the following manner: 1,500,000 stock options on September 1, 2022, 1,500,000 stock options on September 1, 2023, 2,000,000 stock options on September 1, 2024 and the final 2,000,000 stock options on September 1, 2025. All other terms of the former employment agreement remain the same. Other Obligations and Commitments - No new obligation or commitments during the period ending September 30, 2022.

NOTE 13. SUBSEQUENT EVENTS

NOTE 13. SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
NOTE 13. SUBSEQUENT EVENTS	NOTE 13. SUBSEQUENT EVENTS On October 4, 2022, the Company entered into a convertible promissory note with a non-related party for $ 50,000 7 On November 7, 2022, the Company entered into a promissory note with a non-related party for $ 250,000 8 67,500 th th 75,000,000 25,000

NOTE 1. BASIS OF PRESENTATION_2

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basic and Diluted Loss Per Share	Basic and Diluted Loss Per Share Basic income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as options, warrants, convertible notes payable, preferred series A stock and preferred series C stock. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, for the three months and nine months ended September 30, 2022, there were outstanding common share equivalents which amounted to 331,667,447 and 231,733,160 shares of common stock, respectively, that were not included in the calculation as their effect is anti-dilutive. For fiscal periods with net losses, these common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive. Three months ended September 30, 2022 Three months ended September 30, 2021 Nine months Nine months Numerator: Net income (loss) (498,463 ) (146,187 ) 220,544 3,207,572 (Gain) loss on change in fair value of derivative liability — — (1,835,014 ) (1,641,616 ) Gain on settlement of debt — — (69,270 ) (3,792,104 ) Interest expense — — — 30,617 Adjusted net income (loss) (498,463 ) (146,187 ) (1,683,740 ) (2,195,531 ) Denominator: Weighted average shares outstanding used in computing net income (loss) per share Basic 806,882,966 773,082,751 797,708,252 760,229,694 Effect of dilutive warrants — — 101,723,677 203,745,854 Effect of convertible note weighted shares — — 516,700 60,456,989 Diluted 806,882,966 773,082,751 899,948,629 1,024,432,537 Net income (loss) per share applicable to common shareholders: Basic $ (0.00 ) $ (0.00 ) $ 0.00 $ 0.00 Diluted $ (0.00 ) $ (0.00 ) $ (0.00 ) $ (0.00 )
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40)” (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU’s amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its financial statements. The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE 1. BASIS OF PRESENTATION_3

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three months ended September 30, 2022 Three months ended September 30, 2021 Nine months Nine months Numerator: Net income (loss) (498,463 ) (146,187 ) 220,544 3,207,572 (Gain) loss on change in fair value of derivative liability — — (1,835,014 ) (1,641,616 ) Gain on settlement of debt — — (69,270 ) (3,792,104 ) Interest expense — — — 30,617 Adjusted net income (loss) (498,463 ) (146,187 ) (1,683,740 ) (2,195,531 ) Denominator: Weighted average shares outstanding used in computing net income (loss) per share Basic 806,882,966 773,082,751 797,708,252 760,229,694 Effect of dilutive warrants — — 101,723,677 203,745,854 Effect of convertible note weighted shares — — 516,700 60,456,989 Diluted 806,882,966 773,082,751 899,948,629 1,024,432,537 Net income (loss) per share applicable to common shareholders: Basic $ (0.00 ) $ (0.00 ) $ 0.00 $ 0.00 Diluted $ (0.00 ) $ (0.00 ) $ (0.00 ) $ (0.00 )

NOTE 3. PROPERTY AND EQUIPMENT

NOTE 3. PROPERTY AND EQUIPMENT (Tables)	9 Months Ended
	Sep. 30, 2022
PROPERTY AND EQUIPMENT
Property, Plant and Equipment [Table Text Block]	September 30, 2022 December 31, 2021 Leasehold improvements $ 61,846 $ 61,580 Machinery and leased equipment 433,417 365,483 Machinery and equipment not yet in service 732,572 440,150 Office equipment and furniture 99,296 57,913 Website 2,760 2,760 Total property and equipment $ 1,329,891 $ 927,886 Less: Accumulated Depreciation (297,748 ) (165,832 ) Property and equipment, net $ 1,032,143 $ 762,054 Depreciation expense was $ 131,916 66,726 292,422

NOTE 4. INTANGIBLE ASSETS (Tabl

NOTE 4. INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]	September 30, 2022 December 31, 2021 Patents $ 4,505,489 $ 4,505,489 Technology rights 200,000 200,000 Intangibles, at cost 4,705,489 4,705,489 Less: Accumulated amortization (1,833,351 ) (1,607,468 ) Net Carrying Amount $ 2,872,138 $ 3,098,021
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	$ For year ending December 31, 2022 75,501 For year ending December 31, 2023 302,003 For year ending December 31, 2024 302,003 For year ending December 31, 2025 302,003 For year ending December 31, 2026 302,003 Thereafter 1,588,625 Total 2,872,138

NOTE 5. LEASES (Tables)

NOTE 5. LEASES (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Lease, Cost [Table Text Block]	2022 2021 $ Total operating lease cost 40,500 59,750 The following table provides supplemental cashflow and other information related to leases for the nine-month period ended September 30, 2022 and 2021: 2022 2021 $ Lease payments 109,809 127,700 Supplemental balance sheet information related to leases as of September 30, 2022 and 2021 are as below: 2022 2021 $ Cost 123,614 176,213 Accumulated amortization (70,969 ) (44,411 ) Impairment — (39,030 ) Net carrying value 52,645 92,772
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	$ 2022 13,500 2023 45,000 Total minimum lease payments 58,500 Less: amount of lease payments representing effects of discounting (5,855 ) Present value of future minimum lease payments 52,645 Less: current obligations under leases (48,213 ) Lease liabilities, net of current portion 4,432

NOTE 6. Notes Payable (Tables)

NOTE 6. Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Long-Term Debt Instruments [Table Text Block]	Type Original Amount Origination Date Maturity Date Effective Annual Interest Rate Balance at September 30, 2022 Balance at December 31, 2021 Note Payable ** $ 25,000 05/08/2017 06/30/2018 0 % $ 20,000 $ 22,500 Note Payable ** $ 118,644 05/05/2020 05/05/2021 8 % $ 110,644 $ 110,644 Note Payable (a) $ 199,000 02/04/2022 02/03/2023 0 % $ — $ — Note Payable (b) $ 131,100 03/04/2022 12/16/2022 83 % $ 40,457 $ — Note Payable (c) $ 81,600 04/13/2022 01/05/2023 87 % $ 32,063 — Note Payable (d) $ 200,000 7/13/2022 7/11/2023 70 % $ 177,439 — Note Payable (e) $ 57,600 8/15/2022 2/13/2023 171 % $ 44,308 — Sub-total $ 424,911 $ 133,144 Debt discount $ (20,862 ) $ — Balance, net $ 404,049 $ 133,144 Less current portion $ (404,049 ) $ (133,144 ) Total long-term $ — $ — ** Currently in default
Schedule of Debt [Table Text Block]	Type Original Amount Origination Date Maturity Date Annual Interest Rate Balance at September 30, 2022 Balance at December 31, 2021 Note Payable, RP ** $ 17,000 06/20/2018 01/02/2020 5 % $ 10,000 $ 10,000 Note Payable, RP ** $ 50,000 07/27/2018 11/30/2018 8 % $ 10,850 $ 10,850 Note Payable, RP ** $ 15,000 08/16/2019 02/16/2020 8 % $ 15,000 $ 15,000 Note Payable, RP (f) $ 84,034 02/16/2021 Demand 5 % $ 45,000 $ 50,000 Note Payable, RP (g) $ 9,000 06/15/2022 12/31/2022 0 % $ 9,000 $ — Note Payable, RP (g) $ 5,000 06/24/2022 12/31/2022 0 % $ 5,000 $ — Note Payable, RP (g) $ 41,300 06/29/2022 12/31/2022 0 % $ 41,300 $ — Note Payable, RP (h) $ 15,500 07/07/2022 12/31/2022 0 % 15,500 — Note Payable, RP (i) $ 3,500 08/19/2022 12/31/2022 0 % 3,500 — Note Payable, RP (j) $ 22,500 09/02/2022 12/31/2022 0 % 22,500 — Subtotal $ 177,650 $ 85,850 Debt discount $ — $ — Balance, net $ 177,650 $ 85,850 Less current portion $ (177,650 ) $ (85,850 ) Total long-term $ — $ — ** Currently in default
Convertible Debt [Table Text Block]	Type Original Amount Origination Date Maturity Date Annual Interest Rate Balance at September 30, 2022 Balance at December 31, 2021 Convertible Note Payable (k) * ** $ 150,000 04/10/2020 04/09/2021 12 % $ — $ 25,000 Convertible Note Payable (l) $ 300,000 08/27/2020 07/31/2021 12 % $ 265,000 $ 270,000 Convertible Note Payable (m) $ 226,162 11/04/2021 11/04/2022 19 % $ — $ 203,546 Convertible Note Payable $ 1,465,300 11/30/2021 11/30/2023 5 % $ 1,465,300 $ 1,465,300 Convertible Note Payable (n) ** $ 128,000 03/29/2022 03/29/2023 12 % $ 128,000 $ — Convertible Note Payable (o) $ 53,000 06/01/2022 06/01/2023 12 % $ 53,000 $ — Convertible Note Payable (p) $ 53,000 06/14/2022 06/14/2023 12 % $ 53,000 $ — Subtotal $ 1,964,300 $ 1,963,846 Debt discount $ (68,066 ) $ (17,738 ) Balance, net $ 1,896,234 $ 1,946,108 Less current portion $ (430,934 ) $ (480,808 ) Total long-term $ 1,465,300 $ 1,465,300 * Embedded conversion feature accounted for as a derivative liability at period end ** Currently in default

NOTE 7. DERIVATIVE LIABILITIES

NOTE 7. DERIVATIVE LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2022
Note 7. Derivative Liabilities
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	September 30, December 31, Balance at the beginning of period $ 3,044,034 $ 7,102,801 Discount upon recognition of conversion feature 113,348 — Settlement of derivative instruments (69,270 ) (4,035,906 ) Change in fair value of embedded conversion option (2,061,774 ) (22,861 ) Balance at the end of the period $ 1,026,338 $ 3,044,034
Schedule of Assumptions for Fair Value as of Balance Sheet Date of Assets or Liabilities that relate to Transferor's Continuing Involvement [Table Text Block]	Expected Volatility Risk-free Interest Rate Expected Dividend Yield Expected Life (in years) At September 30, 2022 108 199 3.92 4.25 0 % 0.49 2.91

NOTE 9. STOCK OPTIONS (Tables)

NOTE 9. STOCK OPTIONS (Tables)	9 Months Ended
	Sep. 30, 2022
Note 9. Stock Options
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Number of options Weighted average exercise price Balance, December 31, 2021 8,500,000 0.034 Granted 7,000,000 0.067 Expired/Cancelled (6,500,000 ) 0.039 Settled — — Balance, September 30, 2022 9,000,000 0.056 Exercisable 3,500,000 0.021
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 09/01/2021 2,000,000 2,000,000 0.015 3.92 08/31/2026 30,000 04/01/2021 1,500,000 1,500,000 0.03 4.92 08/31/2027 45,000 04/01/2021 1,500,000 — 0.05 5.92 08/31/2028 75,000 04/01/2021 2,000,000 — 0.075 6.92 08/31/2029 150,000 04/01/2021 2,000,000 — 0.10 7.92 08/31/2030 200,000 9,000,000 3,500,000 $ 500,000

NOTE 10. WARRANTS (Tables)

NOTE 10. WARRANTS (Tables)	9 Months Ended
	Sep. 30, 2022
Note 10. Warrants
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Number of Weighted average exercise price Balance, December 31, 2021 115,048,858 0.00597 Cancelled — — Granted — — Exercised — — Balance, September 30, 2022 115,048,858 0.00597
[custom:ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock]	Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 12/3/2018 500,000 500,000 * 0.10 1.18 12/3/2023 50,000 3/31/2019 104,548,858 * 104,548,858 * 0.00035 * 1.45 03/13/2024 36,592 8/26/2020 10,000,000 10,000,000 0.06 2.91 8/26/2025 600,000 115,048,858 115,048,858 $ 686,592 *The number of warrants outstanding and exercisable is variable based on adjustments to the exercise price of the warrant due to dilutive issuances.

Basic and diluted income (loss)

Basic and diluted income (loss) per share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net income (loss)	$ (498,463)	$ (146,187)	$ 220,544	$ 3,207,572
(Gain) loss on change in fair value of derivative liability			(1,835,014)	(1,641,616)
Gain on settlement of debt			(69,270)	(3,792,104)
Interest expense				30,617
Adjusted net income (loss)	$ (498,463)	$ (146,187)	$ (1,683,740)	$ (2,195,531)
Denominator: Weighted average shares outstanding used in computing net income (loss) per share
Basic	806,882,966	773,082,751	797,708,252	760,229,694
Effect of dilutive warrants			101,723,677	203,745,854
Effect of convertible note weighted shares			516,700	60,456,989
Diluted	806,882,966	773,082,751	899,948,629	1,024,432,537
Net income (loss) per share applicable to common shareholders:
Basic	$ 0	$ 0	$ 0	$ 0
Diluted	$ 0	$ 0	$ 0	$ 0

NOTE 2. GOING CONCERN (Details

NOTE 2. GOING CONCERN (Details Narrative) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retained Earnings (Accumulated Deficit)	$ (29,378,449)	$ (29,598,993)
Banking Regulation, Total Capital, Actual	$ (4,123,267)

Property and equipment (Details

Property and equipment (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
PROPERTY AND EQUIPMENT
Leasehold improvements	$ 61,846	$ 61,580
Machinery and leased equipment	433,417	365,483
Machinery and equipment not yet in service	732,572	440,150
Office equipment and furniture	99,296	57,913
Website	2,760	2,760
Total property and equipment	1,329,891	927,886
Less: Accumulated Depreciation	(297,748)	(165,832)
Property and equipment, net	$ 1,032,143	$ 762,054

NOTE 3. PROPERTY AND EQUIPMEN_2

NOTE 3. PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
PROPERTY AND EQUIPMENT
Depreciation	$ 131,916	$ 66,726
[custom:MachineryAndEquipmentNotYetInServiceAdded]	$ 292,422

Intangible assets (Details)

Intangible assets (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Patents	$ 4,505,489	$ 4,505,489
Technology rights	200,000	200,000
Intangibles, at cost	4,705,489	4,705,489
Less: Accumulated amortization	(1,833,351)	(1,607,468)
Net Carrying Amount	$ 2,872,138	$ 3,098,021

Estimated future amortization e

Estimated future amortization expense (Details)	Sep. 30, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
	$ 75,501
	302,003
	302,003
	302,003
	302,003
	1,588,625
	$ 2,872,138

NOTE 4. INTANGIBLE ASSETS (Deta

NOTE 4. INTANGIBLE ASSETS (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of Intangible Assets	$ 225,883	$ 228,366

Components of lease expenses (D

Components of lease expenses (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Total operating lease cost	$ 40,500	$ 59,750
Lease payments	109,809	127,700
Cost	123,614	176,213
Accumulated amortization	(70,969)	(44,411)
Impairment		(39,030)
Net carrying value	$ 52,645	$ 92,772

Future minimum lease payments r

Future minimum lease payments related to lease obligations (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Leases [Abstract]
2022	$ 13,500
2023	45,000
Total minimum lease payments	58,500
Less: amount of lease payments representing effects of discounting	(5,855)
Present value of future minimum lease payments	52,645
Less: current obligations under leases	(48,213)
Lease liabilities, net of current portion	$ 4,432	$ 41,408

NOTE 5. LEASES (Details Narrati

NOTE 5. LEASES (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended			20 Months Ended
	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022
Lessee, Lease, Description [Line Items]
Operating Lease, Expense	$ 13,500
Lease 1 [Member]
Lessee, Lease, Description [Line Items]
Operating Leases, Rent Expense, Net		$ 7,803	$ 7,650	$ 7,500
Lease 2 [Member]
Lessee, Lease, Description [Line Items]
Operating Leases, Rent Expense, Net					$ 4,500

Notes payable (Details)

Notes payable (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
Short-Term Debt [Line Items]
Notes and Loans Payable, Current	$ (404,049)
Notes and Loans Payable, Current	(133,144)
Notes Payable 1 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	25,000
Long-Term Debt, Gross	20,000
Long-Term Debt, Gross	$ 22,500
Debt Instrument, Issuance Date	May 08, 2017
Debt Instrument, Maturity Date	Jun. 30, 2018
Debt Instrument, Interest Rate During Period	0%
Notes Payable 3 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 118,644
Long-Term Debt, Gross	110,644
Long-Term Debt, Gross	$ 110,644
Debt Instrument, Issuance Date	May 05, 2020
Debt Instrument, Maturity Date	May 05, 2021
Debt Instrument, Interest Rate During Period	8%
Notes Payable 12 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 199,000
Long-Term Debt, Gross
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Feb. 04, 2022
Debt Instrument, Maturity Date	Feb. 03, 2023
Debt Instrument, Interest Rate During Period	0%
Notes Payable 13 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 131,100
Long-Term Debt, Gross	40,457
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Mar. 04, 2022
Debt Instrument, Maturity Date	Dec. 16, 2022
Debt Instrument, Interest Rate During Period	83%
Notes Payable 14 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 81,600
Long-Term Debt, Gross	32,063
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Apr. 13, 2022
Debt Instrument, Maturity Date	Jan. 05, 2023
Debt Instrument, Interest Rate During Period	87%
Notes Payable 15 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 200,000
Long-Term Debt, Gross	177,439
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Jul. 13, 2022
Debt Instrument, Maturity Date	Jul. 11, 2023
Debt Instrument, Interest Rate During Period	70%
Notes Payable 16 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 57,600
Long-Term Debt, Gross	44,308
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Aug. 15, 2022
Debt Instrument, Maturity Date	Feb. 13, 2023
Debt Instrument, Interest Rate During Period	171%
Notes Payable Total [Member]
Short-Term Debt [Line Items]
Long-Term Debt, Gross	$ 404,049
Long-Term Debt, Gross	133,144
[custom:NotesPayableSubtotal-2]	424,911
[custom:NotesPayableSubtotal-1]	133,144
Debt Instrument, Unamortized Discount (Premium), Net	(20,862)
Debt Instrument, Unamortized Discount (Premium), Net
Notes and Loans Payable, Current	(404,049)
Notes and Loans Payable, Current	(133,144)
Long-Term Debt, Excluding Current Maturities
Long-Term Debt, Excluding Current Maturities

Notes payable, related parties

Notes payable, related parties (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
Short-Term Debt [Line Items]
Notes Payable, Related Parties, Current	$ 177,650
Notes Payable, Related Parties, Current	85,850
Notes Payable, Related Parties, Current	(177,650)
Notes Payable, Related Parties, Current	(85,850)
Notes Payable Related Party 4 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	17,000
Long-Term Debt, Gross	10,000
Long-Term Debt, Gross	$ 10,000
Debt Instrument, Issuance Date	Jun. 20, 2018
Debt Instrument, Maturity Date	Jan. 02, 2020
Debt Instrument, Interest Rate During Period	5%
Notes Payable Related Party 5 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 50,000
Long-Term Debt, Gross	10,850
Long-Term Debt, Gross	$ 10,850
Debt Instrument, Issuance Date	Jul. 27, 2018
Debt Instrument, Maturity Date	Nov. 30, 2018
Debt Instrument, Interest Rate During Period	8%
Notes Payable Related Party 8 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 15,000
Long-Term Debt, Gross	15,000
Long-Term Debt, Gross	$ 15,000
Debt Instrument, Issuance Date	Aug. 16, 2019
Debt Instrument, Maturity Date	Feb. 16, 2020
Debt Instrument, Interest Rate During Period	8%
Notes Payable Related Party 10 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 84,034
Long-Term Debt, Gross	45,000
Long-Term Debt, Gross	$ 50,000
Debt Instrument, Issuance Date	Feb. 16, 2021
Debt Instrument, Interest Rate During Period	5%
Notes Payable Related Party 11 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 9,000
Long-Term Debt, Gross	9,000
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Jun. 15, 2022
Debt Instrument, Maturity Date	Dec. 31, 2022
Debt Instrument, Interest Rate During Period	0%
Notes Payable Related Party 12 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 5,000
Long-Term Debt, Gross	5,000
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Jun. 24, 2022
Debt Instrument, Maturity Date	Dec. 31, 2022
Debt Instrument, Interest Rate During Period	0%
Notes Payable Related Party 13 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 41,300
Long-Term Debt, Gross	41,300
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Jun. 29, 2022
Debt Instrument, Maturity Date	Dec. 31, 2022
Debt Instrument, Interest Rate During Period	0%
Notes Payable Related Party 14 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 15,500
Long-Term Debt, Gross	15,500
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Jul. 07, 2022
Debt Instrument, Maturity Date	Dec. 31, 2022
Debt Instrument, Interest Rate During Period	0%
Notes Payable Related Party 15 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 3,500
Long-Term Debt, Gross	3,500
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Aug. 19, 2022
Debt Instrument, Maturity Date	Dec. 31, 2022
Debt Instrument, Interest Rate During Period	0%
Notes Payable Related Party 16 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 22,500
Long-Term Debt, Gross	22,500
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Sep. 02, 2022
Debt Instrument, Maturity Date	Dec. 31, 2022
Debt Instrument, Interest Rate During Period	0%
Notes Payable Related Party Total [Member]
Short-Term Debt [Line Items]
Notes Payable, Related Parties, Current	$ 177,650
Notes Payable, Related Parties, Current	85,850
Debt Instrument, Unamortized Discount (Premium), Net
Debt Instrument, Unamortized Discount (Premium), Net
Notes Payable, Related Parties	177,650
Notes Payable, Related Parties	85,850
Notes Payable, Related Parties, Current	(177,650)
Notes Payable, Related Parties, Current	(85,850)
Notes Payable, Related Parties, Noncurrent
Notes Payable, Related Parties, Noncurrent

Convertible notes payable (Deta

Convertible notes payable (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
Short-Term Debt [Line Items]
Convertible Notes Payable, Current	$ (430,934)
Convertible Notes Payable, Current	(480,808)
Convertible Notes Payable, Noncurrent	1,465,300
Convertible Notes Payable, Noncurrent	1,465,300
Convertible Note Payable 4 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	150,000
Long-Term Debt, Gross
Long-Term Debt, Gross	$ 25,000
Debt Instrument, Issuance Date	Apr. 10, 2020
Debt Instrument, Maturity Date	Apr. 09, 2021
Debt Instrument, Interest Rate During Period	12%
Convertible Note Payable 5 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 300,000
Long-Term Debt, Gross	265,000
Long-Term Debt, Gross	$ 270,000
Debt Instrument, Issuance Date	Aug. 27, 2020
Debt Instrument, Maturity Date	Jul. 31, 2021
Debt Instrument, Interest Rate During Period	12%
Convertible Note Payable 19 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 226,162
Long-Term Debt, Gross
Long-Term Debt, Gross	$ 203,546
Debt Instrument, Issuance Date	Nov. 04, 2021
Debt Instrument, Maturity Date	Nov. 04, 2022
Debt Instrument, Interest Rate During Period	19%
Convertible Note Payable 20 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 1,465,300
Long-Term Debt, Gross	1,465,300
Long-Term Debt, Gross	$ 1,465,300
Debt Instrument, Issuance Date	Nov. 30, 2021
Debt Instrument, Maturity Date	Nov. 30, 2023
Debt Instrument, Interest Rate During Period	5%
Convertible Note Payable 21 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 128,000
Long-Term Debt, Gross	128,000
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Mar. 29, 2022
Debt Instrument, Maturity Date	Mar. 29, 2023
Debt Instrument, Interest Rate During Period	12%
Convertible Note Payable 22 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 53,000
Long-Term Debt, Gross	53,000
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Jun. 01, 2022
Debt Instrument, Maturity Date	Jun. 01, 2023
Debt Instrument, Interest Rate During Period	12%
Convertible Note Payable 23 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	$ 53,000
Long-Term Debt, Gross	53,000
Long-Term Debt, Gross
Debt Instrument, Issuance Date	Jun. 14, 2022
Debt Instrument, Maturity Date	Jun. 14, 2023
Debt Instrument, Interest Rate During Period	12%
Convertible Note Payable Total [Member]
Short-Term Debt [Line Items]
Convertible Debt	$ 1,964,300
Convertible Debt	1,963,846
Debt Instrument, Unamortized Discount (Premium), Net	(68,066)
Debt Instrument, Unamortized Discount (Premium), Net	(17,738)
Convertible Debt, Current	1,896,234
Convertible Debt, Current	1,946,108
Convertible Notes Payable, Current	(430,934)
Convertible Notes Payable, Current	(480,808)
Convertible Notes Payable, Noncurrent	1,465,300
Convertible Notes Payable, Noncurrent	$ 1,465,300

NOTE 6. Notes Payable (Details

NOTE 6. Notes Payable (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Short-Term Debt [Line Items]
Repayments of Convertible Debt	$ 120,465	$ 673,989
Notes Payable 12 [Member]
Short-Term Debt [Line Items]
[custom:FutureReceivablesSoldToNonrelatedParty]	199,000
[custom:OriginalIssueDiscountOnNotePayable]	2,985
Proceeds from Other Debt	196,015
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceWeeklyAmount]	5,013
Amortization of Debt Issuance Costs and Discounts	2,985
[custom:RepaidInCashValue]	117,312
[custom:RepaidThroughNewLoansIssuedValue]	122,900
[custom:IncreaseDecreaseSettlementDebt]	1,011
[custom:NoteBalance-0]	$ 0
Debt Instrument, Interest Rate During Period	0%
Notes Payable 13 [Member]
Short-Term Debt [Line Items]
[custom:FutureReceivablesSoldToNonrelatedParty]	$ 131,100
[custom:OriginalIssueDiscountOnNotePayable]	36,100
Proceeds from Other Debt	95,000
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceWeeklyAmount]	3,121
Amortization of Debt Issuance Costs and Discounts	32,518
[custom:NoteBalance-0]	40,457
Repayments of Other Debt	90,643
[custom:DiscountBalanceValue]	$ 3,582
Debt Instrument, Interest Rate During Period	83%
Notes Payable 14 [Member]
Short-Term Debt [Line Items]
[custom:FutureReceivablesSoldToNonrelatedParty]	$ 81,600
[custom:OriginalIssueDiscountOnNotePayable]	21,600
Proceeds from Other Debt	60,000
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceWeeklyAmount]	2,147
Amortization of Debt Issuance Costs and Discounts	18,133
[custom:NoteBalance-0]	32,063
Repayments of Other Debt	49,537
[custom:DiscountBalanceValue]	$ 3,467
Debt Instrument, Interest Rate During Period	87%
Notes Payable 15 [Member]
Short-Term Debt [Line Items]
[custom:FutureReceivablesSoldToNonrelatedParty]	$ 200,000
[custom:OriginalIssueDiscountOnNotePayable]	2,500
Proceeds from Other Debt	74,600
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceWeeklyAmount]	5,308
Amortization of Debt Issuance Costs and Discounts	878
[custom:NoteBalance-0]	177,439
Repayments of Other Debt	42,462
[custom:DiscountBalanceValue]	1,622
Participating Mortgage Loans, Extinguishment Gain (Loss)	$ 122,900
Debt Instrument, Interest Rate During Period	70%
Notes Payable 16 [Member]
Short-Term Debt [Line Items]
[custom:FutureReceivablesSoldToNonrelatedParty]	$ 57,600
[custom:OriginalIssueDiscountOnNotePayable]	17,600
Proceeds from Other Debt	40,000
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceWeeklyAmount]	2,215
Amortization of Debt Issuance Costs and Discounts	8,113
[custom:NoteBalance-0]	44,308
Repayments of Other Debt	13,292
[custom:DiscountBalanceValue]	$ 12,191
Debt Instrument, Interest Rate During Period	171%
Notes Payable Related Party 10 [Member]
Short-Term Debt [Line Items]
[custom:NoteBalance-0]	$ 45,000
Repayments of Other Debt	$ 5,000
Debt Instrument, Interest Rate During Period	5%
Notes Payable Related Party 11 [Member]
Short-Term Debt [Line Items]
[custom:PromissoryNotesIssuedToRelatedParty]	$ 55,300
Debt Instrument, Interest Rate During Period	0%
Notes Payable Related Party 14 [Member]
Short-Term Debt [Line Items]
[custom:PromissoryNotesIssuedToRelatedParty]	$ 15,500
Debt Instrument, Interest Rate During Period	0%
Notes Payable Related Party 15 [Member]
Short-Term Debt [Line Items]
[custom:PromissoryNotesIssuedToRelatedParty]	$ 3,500
Debt Instrument, Interest Rate During Period	0%
Notes Payable Related Party 16 [Member]
Short-Term Debt [Line Items]
[custom:PromissoryNotesIssuedToRelatedParty]	$ 22,500
Debt Instrument, Interest Rate During Period	0%
Convertible Note Payable 4 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate During Period	12%
Repayments of Convertible Debt	$ 25,000
[custom:ConvertibleNotePayableOutstandingDebtBalance-0]	$ 0
Convertible Note Payable 5 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate During Period	12%
Repayments of Convertible Debt	$ 5,000
[custom:ConvertibleNotePayableOutstandingDebtBalance-0]	265,000
Convertible Note Payable 19 [Member]
Short-Term Debt [Line Items]
Amortization of Debt Issuance Costs and Discounts	$ 17,738
Debt Instrument, Interest Rate During Period	19%
Repayments of Convertible Debt	$ 90,465
[custom:ConvertibleNotePayableOutstandingDebtBalance-0]	$ 0
Stock Issued During Period, Shares, Conversion of Convertible Securities	16,644,146
Convertible Note Payable 21 [Member]
Short-Term Debt [Line Items]
Amortization of Debt Issuance Costs and Discounts	$ 52,436
Debt Instrument, Interest Rate During Period	12%
[custom:ConvertiblePromissoryNoteIssued]	$ 128,000
[custom:ConvertibleDebtOriginalIssueDiscount]	500
[custom:ConvertibleDebtIssuanceCosts]	2,500
[custom:DiscountRelatedToInitialFairValueOfDerivativeConversionFeature]	113,348
Convertible Note Payable 22 [Member]
Short-Term Debt [Line Items]
Amortization of Debt Issuance Costs and Discounts	$ 976
Debt Instrument, Interest Rate During Period	12%
[custom:ConvertiblePromissoryNoteIssued]	$ 53,000
[custom:ConvertibleDebtOriginalIssueDiscount]	500
[custom:ConvertibleDebtIssuanceCosts]	2,500
Proceeds from Debt, Net of Issuance Costs	50,000
Convertible Note Payable 23 [Member]
Short-Term Debt [Line Items]
Amortization of Debt Issuance Costs and Discounts	$ 870
Debt Instrument, Interest Rate During Period	12%
[custom:ConvertiblePromissoryNoteIssued]	$ 53,000
[custom:ConvertibleDebtOriginalIssueDiscount]	500
[custom:ConvertibleDebtIssuanceCosts]	2,500
Proceeds from Debt, Net of Issuance Costs	$ 50,000

Summary of changes in the fair

Summary of changes in the fair value of the Company's Level 3 financial liabilities (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Note 7. Derivative Liabilities
Balance at the beginning of period	$ 3,044,034	$ 7,102,801
Discount upon recognition of conversion feature	113,348
Settlement of derivative instruments	(69,270)	(4,035,906)
Change in fair value of embedded conversion option	(2,061,774)	(22,861)
Balance at the end of the period	$ 1,026,338	$ 3,044,034

Assumptions used to calculate f

Assumptions used to calculate fair value of derivative liabilities (Details) - Trading Liabilities [Member]	9 Months Ended
	Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	108%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	199%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum	3.92%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	4.25%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0%
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]	5 months 26 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	2 years 10 months 28 days

NOTE 8. STOCKHOLDERS' DEFICIT (

NOTE 8. STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended				9 Months Ended		12 Months Ended	21 Months Ended
	Dec. 31, 2018	Jun. 30, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Sep. 30, 2020	Dec. 02, 2021	Sep. 18, 2019	Aug. 13, 2019	Apr. 12, 2019	Mar. 23, 2018
Class of Stock [Line Items]
Preferred Stock, Shares Authorized														10,000,000
Preferred Stock, Par or Stated Value Per Share														$ 0.001
[custom:PreferredSeriesAStockOfferingAuthorized]	1,000,000
[custom:PreferredSeriesAStockOfferingAuthorizedOfferingPrice]	$ 0.10
[custom:ProceedsFromPreferredSeriesAStockSubscriptions]	$ 60,000
[custom:StockIssuedDuringPeriodSharesPreferredSeriesAStockSubscriptions]	600,000
[custom:StockIssuedDuringPeriodToOfficersSeriesBPreferredStock]									1,000,000
[custom:InitialRedemptionAmountOfSeriesBPreferredStockClassifiedAsMezzanineEquityValue]									$ 158,247
[custom:ProceedsFromIssuanceOrSaleOfEquityPreferredStock]								$ 2,250,000
Common Stock, Shares Authorized						1,000,000,000		1,000,000,000
Common Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001
Common Stock, Shares, Outstanding						805,596,961		790,924,690
Stock Issued During Period, Value, Conversion of Convertible Securities		$ 125,520	$ 124,000		$ 25,000
Common Stock [Member]
Class of Stock [Line Items]
[custom:CommonStockIssuedInConversionOfPreferredSeriesCStockShares]					4,000,000		4,000,000
Sale of Stock, Number of Shares Issued in Transaction				8,750,000
Stock Issued During Period, Value, Conversion of Convertible Securities		$ 16,644	$ 8,000		$ 25,000
Stock Issued During Period, Shares, Conversion of Convertible Securities		16,644,146	8,000,000		25,000,000
Chief Financial Officer [Member]
Class of Stock [Line Items]
[custom:StockIssuedDuringPeriodToOfficersSeriesBPreferredStock]									500,000
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized						1,000,000		1,000,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001
[custom:PreferredStockSharesDesignated-0]													1,000,000
Preferred Stock, Shares Outstanding						500,000		500,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized						1,000,000		1,000,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001
[custom:PreferredStockSharesDesignated-0]												1,000,000
Preferred Stock, Shares Outstanding						1,000,000		1,000,000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized						1,500,000		1,500,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001
[custom:PreferredStockSharesDesignated-0]										1,500,000	5,500,000
Preferred Stock, Shares Outstanding						1,500,000		1,500,000
[custom:ConversionOfPreferredSeriesCStockShares]							40,000
Sale of Stock, Number of Shares Issued in Transaction								1,500,000
Common Stock 1 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities						$ 12,500
Stock Issued During Period, Shares, Conversion of Convertible Securities						1,453,488
Common Stock 2 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities						$ 12,500
Stock Issued During Period, Shares, Conversion of Convertible Securities						1,506,024
Common Stock 3 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities						$ 15,000
Stock Issued During Period, Shares, Conversion of Convertible Securities						1,973,684
Common Stock 4 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities						$ 20,000
Stock Issued During Period, Shares, Conversion of Convertible Securities						2,597,403
Common Stock 5 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities						$ 30,000
Stock Issued During Period, Shares, Conversion of Convertible Securities						3,947,368
Common Stock 6 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities						$ 20,000
Stock Issued During Period, Shares, Conversion of Convertible Securities						2,702,703
Common Stock 7 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities						$ 15,520
Stock Issued During Period, Shares, Conversion of Convertible Securities						2,463,476
Common Stock 8 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities						1,971,875

Summary of options issued and o

Summary of options issued and outstanding (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Note 9. Stock Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Beginning Balance | shares	8,500,000
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 0.034
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross | shares	7,000,000
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares	$ 0.067
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period | shares	(6,500,000)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | $ / shares	$ 0.039
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares | shares
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance | shares	9,000,000
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price, Ending Balance | $ / shares	$ 0.056
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number | shares	3,500,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ / shares	$ 0.021

Stock options outstanding (Deta

Stock options outstanding (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Offsetting Assets [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	9,000,000	8,500,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number	3,500,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.021
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	4 years 11 months 1 day
Proceeds from Stock Options Exercised	$ 500,000
Stock Option 2 [Member]
Offsetting Assets [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number	2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.015
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	3 years 11 months 1 day
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Aug. 31, 2026
Proceeds from Stock Options Exercised	$ 30,000
Stock Option 3 [Member]
Offsetting Assets [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	1,500,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number	1,500,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.03
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Aug. 31, 2027
Proceeds from Stock Options Exercised	$ 45,000
Stock Option 4 [Member]
Offsetting Assets [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	1,500,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.05
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	5 years 11 months 1 day
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Aug. 31, 2028
Proceeds from Stock Options Exercised	$ 75,000
Stock Option 5 [Member]
Offsetting Assets [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.075
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	6 years 11 months 1 day
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Aug. 31, 2029
Proceeds from Stock Options Exercised	$ 150,000
Stock Option 6 [Member]
Offsetting Assets [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.10
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	7 years 11 months 1 day
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Aug. 31, 2030
Proceeds from Stock Options Exercised	$ 200,000

NOTE 9. STOCK OPTIONS (Details

NOTE 9. STOCK OPTIONS (Details Narrative) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Note 9. Stock Options
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price	$ 0.056	$ 0.034
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.021
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$ 0

Summary of the continuity of sh

Summary of the continuity of share purchase warrants (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Note 10. Warrants
Class of Warrant or Right, Outstanding | shares	115,048,858
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 0.00597
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations | shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | $ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted | shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised | shares
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice] | $ / shares
Class of Warrant or Right, Outstanding | shares	115,048,858
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 0.00597

Share purchase warrants outstan

Share purchase warrants outstanding (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Class of Warrant or Right, Outstanding	115,048,858	115,048,858
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable-0]	115,048,858
Proceeds from Warrant Exercises	$ 686,592
Warrant [Member]
Class of Warrant or Right, Outstanding	500,000
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable-0]	500,000
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePrice-0]	$ 0.10
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	1 year 2 months 4 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Dec. 03, 2023
Proceeds from Warrant Exercises	$ 50,000
Warrant 1 [Member]
Class of Warrant or Right, Outstanding	104,548,858
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable-0]	104,548,858
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePrice-0]	$ 0.00035
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	1 year 5 months 12 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Mar. 13, 2024
Proceeds from Warrant Exercises	$ 36,592
Warrant 2 [Member]
Class of Warrant or Right, Outstanding	10,000,000
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable-0]	10,000,000
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePrice-0]	$ 0.06
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	2 years 10 months 28 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Aug. 26, 2025
Proceeds from Warrant Exercises	$ 600,000

NOTE 10. WARRANTS (Details Narr

NOTE 10. WARRANTS (Details Narrative)	Sep. 30, 2022 USD ($)
Note 10. Warrants
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding	$ 737,069

NOTE 12. COMMITMENTS AND CONT_2

NOTE 12. COMMITMENTS AND CONTINGENCIES (Details Narrative)	9 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares
Commitments and Contingencies Disclosure [Abstract]
[custom:ConsultingAgreementPeriodicPayment] | $	$ 5,000
[custom:ConsultingAgreementCommonStockIssuedShares] | shares	2,500,000
[custom:ConsultingAgreementCommonStockIssuedExercisePricePerShare] | $ / shares	$ 0.0001

NOTE 13. SUBSEQUENT EVENTS (Det

NOTE 13. SUBSEQUENT EVENTS (Details Narrative) - USD ($)		1 Months Ended
	Oct. 04, 2022	Nov. 07, 2022
Subsequent Event 1 [Member]
[custom:ConvertiblePromissoryNoteIssued]	$ 50,000
Debt Instrument, Interest Rate During Period	7%
Subsequent Event 2 [Member]
[custom:ConvertiblePromissoryNoteIssued]		$ 250,000
Debt Instrument, Interest Rate During Period		8%
Debt Instrument, Periodic Payment		$ 67,500
[custom:PromissoryNoteSecuredByRestrictedCommonStockShares]		75,000,000
[custom:PromissoryNoteLatePaymentPenalty]		$ 25,000